Dr. Edward Gerstenfeld, MD

Dr. Gerstenfeld practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Gerstenfeld's NPI, 1972531788, was assigned on June 29, 2006. Dr. Gerstenfeld graduated from Feinberg School of Medicine in 1993. Dr. Gerstenfeld's Pennsylvania license number on file is MD417476.

Dr. Gerstenfeld's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Gerstenfeld's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Gerstenfeld is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Gerstenfeld to 3 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerstenfeld practices, 8 sites in all. Vendor and product names are available with a free account.

Clinical cardiac electrophysiology is Dr. Gerstenfeld's primary specialty in the NPI Registry, under taxonomy code 207RC0001X. Dr. Gerstenfeld is board certified in clinical cardiac electrophysiology by the American Board of Internal Medicine. Dmand AI has Dr. Gerstenfeld's licenses on file in 3 states: Pennsylvania, California and Massachusetts.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. Gerstenfeld treats.

CMS data shows 4,938 Medicare services from Dr. Gerstenfeld across 20 procedure codes in 2024, for 2,741 Medicare patients. Medicare paid $155,144 for them.

CMS counts 2,741 Medicare patients who saw Dr. Gerstenfeld in 2024. The largest group is 65 to 74, with 997 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gerstenfeld's median patient age at 66, with 46% women.

In 2024, Dr. Gerstenfeld wrote 1,178 Medicare Part D claims for 244 patients. 62% of them were for generic drugs. CMS names the drug for 1,103 of them, across 17 drugs with 11 or more claims each, at $603,022 in total drug cost. In 2023, CMS named 1,132 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Gerstenfeld for performance year 2024, reported individually. Dr. Gerstenfeld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gerstenfeld as offering telehealth. CMS counts 15 procedures of pacemaker insertion or repair by Dr. Gerstenfeld, more than 66% of the clinicians it reports for that procedure.

Dmand AI links 87 papers to Dr. Gerstenfeld, published from 2017 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Catheter Ablation, Atrial Fibrillation and Electrocardiography. Dr. Gerstenfeld has published most often in JACC Clin Electrophysiol. Dr. Gerstenfeld's most frequent co-authors are Henry H. Hsia, MD, Melvin M. Scheinman, MD and Gregory Maurice Marcus, MD.

CMS Open Payments shows 320 general payments to Dr. Gerstenfeld from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Boston Scientific Corporation paid the most, $94,718. It also lists 1 research payment totaling $20 in 2016.

Dr. Gerstenfeld graduated from Feinberg School of Medicine in 1993.

Dr. Gerstenfeld is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.